What Researchers Did
Researchers described the Air Force Research Laboratory's experience using ground-level oxygen (GLO) to treat altitude decompression sickness (DCS) in 2001 research subject-exposures.
What They Found
Out of 2001 altitude chamber subject-exposures, 801 subjects (40.0%) were diagnosed with altitude decompression sickness. Of the 749 subjects who received two hours of ground-level oxygen treatment, 739 (98.7%) experienced complete symptom resolution and required no further intervention.
What This Means for Canadian Patients
This study suggests that ground-level oxygen treatment is highly effective for altitude decompression sickness. Canadian patients experiencing altitude decompression sickness could potentially benefit from similar ground-level oxygen protocols, offering a practical treatment option.
Canadian Relevance
This study has no direct Canadian connection, as it describes the Air Force Research Laboratory's experience and supports current USAF guidelines.
Study Limitations
A key limitation is that this was not an operational study, meaning the findings are based on research subjects in a controlled altitude chamber rather than real-world scenarios.